Ara
Toplam kayıt 861, listelenen: 831-840
Modulatory therapy experience in patients with cystic fibrosis in Turkey: A multi-center study
(European Respiratory Society Journals Ltd., 2023)
Background: Modulatory therapies are not reimbursed in Turkey and approach to the treatment is currently available for three months only by court decision. In between the court decisions, most of the patients could not ...
Impact of SPARC expression on pembrolizumab treatment response and prognostic role in advanced stage non-small cell lung cancer
(Lippincott Williams & Wilkins, 2023)
...
KEYFORM-008: Coformulated favezelimab and pembrolizumab (MK4280A) versus chemotherapy in relapsed/refractory classical Hodgkin lymphoma.
(Lippincott Williams & Wilkins, 2023)
...
Triggers and regulation: The gut microbiome in rheumatoid arthritis
(Taylor and Francis Ltd., 2023)
Introduction Rheumatoid arthritis is a chronic inflammatory disease marked by systemic symptoms and joint degeneration. Interestingly, the development and progression of rheumatoid arthritis have been linked to the microbiome, ...
Long-term course of COVID-19 vaccination-related headache: A prospective multicenter follow-up study
(SAGE Publications Ltd, 2023)
...
Real-life experiences with galcanezumab disclosed new predictors for response
(SAGE Publications Ltd, 2023)
...
Vascular comorbidity and cognition in migraine
(SAGE Publications Ltd, 2023)
...